BioPlus Acquisition Corp - Units (1 Ord Share Class A & 1/2 War) BIOSU Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$10.80 down $0.04, 0.37% at close Oct 6
Last close · Previous close $10.84
- Market cap
- $249.05MAt the Oct 6 close
- Dividend yield
- NoneLast 12 months
Price chart
$10.80down $0.10, 0.92%Past month
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$10.84Oct 5
- Volume700.00Oct 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume123.00Last 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Oct 6 close. Total return includes reinvested dividends.Price change only, without dividends.
| Period | BIOSU |
|---|---|
| Short term | |
| 1M | BIOSU: down 0.9% |
| 3M | BIOSU: up 0.6% |
| YTD | BIOSU: up 5.9% |
| 1Y | BIOSU: up 7.5% |
$10,000 invested in BIOSU a year ago (Oct 6, 2022) would be worth about $10,746 at the close on , with dividends reinvested.
| Period | BIOSU |
|---|---|
| Short term | |
| 1M | BIOSU: down 0.9% |
| 3M | BIOSU: up 0.6% |
| YTD | BIOSU: up 5.9% |
| 1Y | BIOSU: up 7.5% |
$10,000 invested in BIOSU a year ago (Oct 6, 2022) would be worth about $10,746 at the close on , not counting dividends.
All-time high
$11.07
Closing high on . Now 2.4% below that record.
Split-adjusted daily closes since Dec 3, 2021.
Stock splits
BIOSU hasn’t split since its price history begins in 2021.
Valuation
The Oct 6 close compared with reported results. 12-month figures aren’t available until four quarters are reported. Tap a metric to see how it’s calculated.
Price-to-earnings (P/E)
Not available
12-month figures aren’t available until four quarters are reported.
Other valuation measures
- 13,846.2×Book value as of Sep 30, 2021
Price relative to accounting equity (book value) per share on the Sep 30, 2021 balance sheet. Asset-light companies often trade far above book value.
P/B = Price ÷ Book value per sharePrice-to-book ratio - $249.18MAt the Oct 6 close
What it would cost to buy the whole business: the market cap at the Oct 6 close, plus debt, minus cash and short-term investments from the Sep 30, 2021 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own BIOSU DCF in Excel. Value BioPlus Acquisition Corp - Units (1 Ord Share Class A & 1/2 War) with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q3 FY21, the quarter ended Sep 30, 2021, and balance-sheet figures are as of Sep 30, 2021. 12-month figures aren’t available until four quarters are reported.
Revenue and net income
12-month figures aren’t available until four quarters are reported.
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q1 FY21 (Mar 18, 2021) | Not reported | Not reported | Not reported |
| Q3 FY21 (Sep 30, 2021) | $0.00 | −$7.02K | $0.00 |
| Period | Revenue | Net income | Diluted EPS |
|---|
Margins
- Gross
- Operating
- Net
The lines show each quarter. What margins tell you
Cash flow
12-month figures aren’t available until four quarters are reported.
Shareholder returns
12-month figures aren’t available until four quarters are reported.
Balance sheet
- $936.00As of Sep 30, 2021
Cash plus short- and long-term marketable securities on the Sep 30, 2021 balance sheet.
- Total debt$130.00KAs of Sep 30, 2021
- Net debt$129.06KAs of Sep 30, 2021
- 0.01As of Sep 30, 2021
Current assets divided by current liabilities on the Sep 30, 2021 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 7.23As of Sep 30, 2021
Total debt divided by shareholders’ equity on the Sep 30, 2021 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
12-month figures aren’t available until four quarters are reported.
About BioPlus Acquisition Corp - Units (1 Ord Share Class A & 1/2 War)
BioPlus Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
- Sector
- Industrials
- Industry
- Shell Companies
- Headquarters
- New York, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
BIOSU news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
BIOSU stock FAQ
What is BIOSU stock’s price today?
BioPlus Acquisition Corp - Units (1 Ord Share Class A & 1/2 War) (BIOSU) traded at $10.80 at the close on , down $0.04 (0.37%) from the previous close of $10.84.
What is BioPlus Acquisition Corp - Units (1 Ord Share Class A & 1/2 War)’s market cap?
BioPlus Acquisition Corp - Units (1 Ord Share Class A & 1/2 War)’s market capitalization is about $249.0 million. That’s Tiingo’s daily market cap for , at that day’s closing price of $10.80 (how market cap works). BioPlus Acquisition Corp - Units (1 Ord Share Class A & 1/2 War) reported 23.06M shares outstanding at the end of its latest quarter ().
Does BIOSU pay a dividend?
BioPlus Acquisition Corp - Units (1 Ord Share Class A & 1/2 War) hasn’t paid a dividend in the last twelve months.
What is BIOSU’s all-time high?
BIOSU’s highest closing price was $11.07 on , adjusted for stock splits. At $10.80 at the close on , it is 2.4% below that record.
Has BIOSU stock ever split?
No. BIOSU hasn’t split since its price history begins in 2021.
How has BIOSU stock performed?
Including dividends and measured to the close on , BIOSU has returned +5.9% so far this year and +7.5% over the past year. Past performance doesn’t predict future returns.
What sector and industry is BioPlus Acquisition Corp - Units (1 Ord Share Class A & 1/2 War) in?
BioPlus Acquisition Corp - Units (1 Ord Share Class A & 1/2 War) is in the Industrials sector and the Shell Companies industry, and is headquartered in New York, USA.
What exchange does BIOSU trade on?
BioPlus Acquisition Corp - Units (1 Ord Share Class A & 1/2 War) trades on the Nasdaq under the ticker symbol BIOSU. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.